Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials

Russia has announced that its novel cancer vaccine, Enteromix, has demonstrated 100% efficacy and safety in initial human trials. The news highlights the vaccine’s remarkable performance: patients experienced tumour shrinkage and no serious side effects. Developed using the same mRNA technology as the COVID-19 vaccines, Enteromix is designed to train the immune system to recognize…

Read More

You cannot copy content of this page